The FDA vaccination committee's decision does not bind the agency, but it does approve its recommendations • Most experts have supported the view that younger adolescents should be vaccinated, and not just 18-year-olds • Health Minister Edelstein: "I instructed my office staff to check the approval, their recommendations Will be submitted within days "
After the US Food and Drug Administration (FDA)'s vaccination committee recommended tonight (Friday) to agency heads to grant emergency approval for Pfizer's corona vaccine, more details are being revealed about the dramatic vote that could change the global fight against the virus.
Biden: 100 million vaccines for Corona in the first 100 days of my term // Photo: Reuters
The decision, which was passed by a majority of 17 supporters against four opponents, is not binding, but the FDA usually approves the committee's recommendations - and there is expected to approve the use of the vaccine in the next day.
The original proposal included that the approval be given to those aged 18 and over, but in the end it was decided that the vaccine would be granted to those aged 16 and over, after a discussion among committee members about the effectiveness of the vaccine among adolescents aged 18-16.
The committee members who approved the use of the vaccine are hospital administrators and external experts on American vaccines, including Dr. Paul Opit, director of the Children's Center at the Philadelphia Hospital. They wanted to highlight the question of allergies and various side effects caused by the use of the vaccine. Such.
Health Minister Yuli Edelstein welcomed the approval, saying that it was a huge decision for the citizens of Israel as well: "I instructed my office staff to check the approval and submit their recommendations in the coming days. Meanwhile, the Ministry of Health continues to progress and prepare for a large-scale vaccination campaign." ".
